Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced #melanoma #cancer. https://t.co/WvwtztXbxo
【薬物動態研究】コビメチニブ+ベムラフェニブを受けている進行黒色腫患者において、23日目の血漿ベムラフェニブ濃度(Css,min)閾値50mg/Lは無増悪生存期間および生存期間と強く関連した。 https://t.co/6cXJHyTHcn
RT @ingentium_mel: Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced #melanoma #cancer…
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced #melanoma #cancer. https://t.co/o4Rqnlp51k
Relationship between #vemurafenib plasma concentrations and survival outcomes in patients with advanced #melanoma https://t.co/oI3iNUp7CM
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma. https://t.co/8GOSJKEK4m
New article: Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma. https://t.co/crwWjqq3DN #melanoma #oncology